When intermediate care is provided, a 500% increase in survival rates can be expected for young Malians with T1D
When intermediate care is provided, the onset of diabetes complications (e.g., kidney failure, blindness) are significantly reduced.
Further, thirty year costs per individual for ‘intermediate’ care requires a lower upfront cost than minimal care ($35,067 v $22,939 USD).
A Healthy Life Year for ‘intermediate’ T1D care per person [as a percentage of Mali’s GDP] is 141% (compared to 492% for minimal care).
This is a cost-effective intervention according to the WHO CHOICE methodology.